MEDIFAST (MED)
(Delayed Data from NYSE)
$24.99 USD
-0.73 (-2.84%)
Updated May 10, 2024 04:00 PM ET
After-Market: $24.96 -0.03 (-0.12%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth B Momentum A VGM
Medifast (MED) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$25.00 | $25.00 | $25.00 | -2.80% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $25.00. The forecasts range from a low of $25.00 to a high of $25.00. The average price target represents a decline of 2.8% from the last closing price of $25.72.
Analyst Price Targets (2 )
Broker Rating
Medifast currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/1/2024 | Stephens | Jim Salera | Hold | Hold |
4/30/2024 | D.A. Davidson | Linda B Weiser | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $25.00 |
LT Growth Rate | NA |
Industry | Food - Miscellaneous |
Industry Rank by ABR | 100 of 252 |
Current Quarter EPS Est: | NA |